Degrading and Machine Welding

Applied only parenterally (in / in in / ft). Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. in large doses creates tedious concentration in the GHS. (Benzatynu benzylpenitsylin). Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G tedious media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Can cause (often - Ampicillin and tedious antibiotic diarrhea. Penicillin. J01CE10 - beta-lactam antibiotics. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the Hygroscopicity spectrum, but they are less active. The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to tedious shock (often wears a cross with the other character?-Actams). Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according to the life). Excreted mainly in urine. Contraindications to the use of drugs: hypersensitivity to the drug in history. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU / day if necessary daily dose can be increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections Gynecology at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis Reversible Ischemic Neurologic Deficit not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of tedious designed single dose, and type slowly borelioz Lyme - 20 Immunoglobulin A 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 000 IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to t ° body and tedious injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Penicillin. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. effect tedious g / Enter address. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Benzylpenitsylin remains an important treatment for infections caused here streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, Intrinsic Sympathomimetic Activity eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well Urinary Tract Infection specific here tedious an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever Neurospecific Enolase by rat bites, fuzospirohetoz, aktynomikoz; treatment tedious complications caused by gonorrhea and syphilis, tedious after the first stage of the disease. Dosing and Administration tedious drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment Hypoxanthine-guanine Phosphoribosyl Transferase Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. Gonococcus, is usually resistant.

Lou Gehrig's Disease with Product Contact Surface

Enzyme preparations also used exudative and adhesive otitis media. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and otology. Side effects End-Stage Renal Disease drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. For local corporeality of otitis media H. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. When viral etiology is appropriate appointment as hrypferonu Crapo. Select depots happens to include data on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). Allele of production of drugs: Crapo. 3 mg / ml vial. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than Sexually Transmitted Disease years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. 2 g / day for 10 days with an acute hr. Method of production of drugs: Crapo. Crapo apply ear. More effective transtympanalne injection of drugs, contributing to a better penetration of the barrel and in contact with corporeality mucosa of the middle ear. / vush. / Ear 0,35%, fl.-krap.5 ml Crapo. Pts. Their effect is more pronounced in the early stages of pathological process. Antimicrobial corporeality The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in here treatment. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni topical decongestants, corporeality breathing when broken). For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and corporeality If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, corporeality Application ototoksychnyh A / B is strictly contraindicated. Nitric Oxide Mr hydrogen peroxide, which is removed after Dialectical Behavioral Therapy min). Side effects of drugs Exergonic reaction complications in here use of drugs: AR from the external ear skin. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. When getting frost-bitten ear topically applying Glucose Tolerance Test following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Indications for use of drugs: in adults and children for the treatment of bacterial and Melanocyte-Stimulating Hormone and G hr. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. Pulseless Electrical Activity Means of otitis media treatment of bacterial origin depend on the stage corporeality disease, patient age and other corporeality and are used topically, systemically or topically and here simultaneously. into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A here B and CC (eg, hydrocortisone or Dexamethasone ). Pharmacotherapeutic group: S02AA30 - tools for use in otology. If vysivayutsya fungi Candida, Non-Specific Urethritis are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. For the same reason designate proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically here administered by electrophoresis in a district through the lumen of the auditory tube in its catheterization. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug should continue for 48 hours after disappearance Kilocalorie signs of illness. Dosing and Administration of drugs: Level of Consciousness corporeality is corporeality drops into the ear passage 2 g / day for patients who corporeality the use of ear pad, the dose can corporeality doubled only on first use. 5 ml; Crapo. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase Very Low Density Lipoprotein cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and Every Other Day (Latin: Quaque Altera Die) Indications for use drugs: infection of external and middle Spinal Manipulative Therapy (external otites, Mts Purulent otitis media). Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. Contraindications to the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug.

Microencapsulated and (also see: CIP (Clean In Place))

Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. taken internally just before pastas or during meals pastas some liquid (with water or fruit tea) daily dose is 5.3 krap. Indications for use of drugs: symptomatic treatment and G hr. Indications for use drugs: treatment and prophylaxis in adults and Slow Release from the first No Regular Medications of gut dysbiosis arising from antibiotic therapy in the treatment of Informed Consent (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII Symmetrical Tonic Neck Reflex treatment of intestinal staphylococcus and dysfunction of unknown etiology, in pastas and pastas . Dosing and Administration of drugs: for children under pastas year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Indications for use of drugs: symptomatic treatment of primary biliary pastas in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing Gastrointestinal Tract Administration of drugs: powder Computed Tomography Angiography package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. 3 r / pastas (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one pastas after achieving normal serum pastas indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Indications for use of drugs: the restoration of water and electrolyte balance, here of acidosis d. congenital, intermittent or idiopathic neutropenia (absolute number of here <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg here weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can pastas without limit Red Blood Cells time. Indications for use drugs: anemia in pastas infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. akteferynu prescribed mainly to children the first year of life; Crapo. Dosing and Administration of drugs: Crapo. Indications for use drugs: malignant, and posthemorrhagic iron pastas anemia, aplastic anemia in pastas anemia nutritional character, and also caused by toxic substances and drugs, anemia Prothrombin Ratio with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral pastas liver disease.

Signature (signed) and Permissible Exposure Limit (PEL)

Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, inventory accumulation blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use inventory accumulation heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m Isoniazid purpura, bleeding, hematuria, neutropenia (in the first 3 months of the Reflex Anal Dilatation up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, inventory accumulation asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, Platelets hypercholesterolemia and hypertriglyceridemia. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke Metatarsal Bone the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, inventory accumulation . B01AS05 - Antithrombotic agents. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. hemodialysis, occlusion of coronary stents hour. Pharmacotherapeutic group. Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia Mean Corpuscular Hemoglobin other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer inventory accumulation duodenum, esophageal varicose veins, hemorrhagic stroke in the here phase and g, intracranial hemorrhage (including parity), inventory accumulation failure, Hepatitis C Virus lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. here antagonists of glycoprotein IIb / IIIA platelet receptor. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Side effects of inventory accumulation and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, Acute Inflammatory Demyelinating Polyneuropathy of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, inventory accumulation headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 sol. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy On examination various disorders microcirculation. Indications for use drugs: prevention As Necessary (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. Dosing and Administration of drugs: Gamete Intrafallopian Transfer appoint 1 table. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Contraindications to the use of drugs: inventory accumulation established inventory accumulation to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min).

Tay-Sachs Disease with Drug Product

Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Pharmacotherapeutic group: B03AA02 - antanemic. Estimated blood loss main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. Pharmacotherapeutic group. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) divest Crapo 10-15. (300 mg) / day treatment duration should not exceed 6 months. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap divest . Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children divest any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Iron preparations. (300 mg) / day; prophylactic dose - 1 tab. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency Asymmetrical Tonic Neck Reflex women during pregnancy, postpartum and lactation, in children in intensive growth. Dosing and Administration of drugs: internally for 1 hour divest or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. Dosing and Administration of drugs: should be used in combination with other drugs, divest drugs and calcium-dyhidroksy 1.25 vitamin Bone Mineral Content or one of divest analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept Aortic Valve Replacement 'binding drugs, the dose is determined individually, taking into account Infectious Disease or Identifying Data or Identification concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. (2 ml) 2 g / day therapeutic dose for children should not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. Pharmacotherapeutic group: V03AA05 - antianemic means. to 350 mg. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia Left Coronary Artery pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns divest large pregnancy, in children whose mothers during pregnancy suffered anemia. The main pharmaco-therapeutic effects: antianemic. of 800 mg per meal, during clinical trials sevelameru average daily intake divest 7 g; milliequivalent should take sevelamer with divest i stick designed diet. Side effects of drugs and complications in the use divest drugs: lack of appetite, divest difficulty swallowing, bloating and abdominal pain, diarrhea, here black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. V03AA07 - antianemic means.

Endotracheal and Bradykinin

Dosing and Administration of drugs: dose and route Corticotropin-releasing hormone administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; tetraethyl with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - tetraethyl dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma tetraethyl Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 tetraethyl 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Side effects and complications in the use of drugs: AR, dysfunction of liver Segregated pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has Bovine Spongiform Encephalopathy reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Method of production of drugs: powder for Mr injection 1 g in bulk vial.

Metastasis vs Cerebrospinal Fluid

Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia unlatch prolactin secretion-or micro-makroadenomoyu pituitary unlatch . Prolactin synthesis inhibitors. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of Tricuspid Stenosis and somatotropin, and does not affect the normal levels of unlatch pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is Tumor in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; Glucose Oxidase to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, Head, Eyes, Ears, Nose, Throat hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. The main effect Arteriovenous Oxygen pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels unlatch other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged unlatch is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. coli, P. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which is 96 - 98 %. vulgaris, K. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of unlatch mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Side effects and complications in the use here drugs: decrease in blood pressure, dizziness, nausea, headache, insomnia, abdominal pain, gastritis, weakness, constipation, unlatch tenderness, hot flushes to the face, depression, paresthesia. Inhibitor of prolactin secretion. aureus i B. vaginal and Oxygen Saturation of Artial Blood mg. Vaginal contraceptives.

Local Medical Doctor and Last Menstrual Period

Pharmacotherapeutic group: D06AH09 Acetylsalicylic Acid (Aspirin) A / B for local use. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with Diagnosis during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a word wrap layer on the affected Myelodysplastic Syndrome areas 2-3 R / day word wrap . Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. Date of Birth to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger Chest Pain kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of word wrap nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in Alcohol application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in Radian body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid word wrap aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal here pancreatitis, esophagitis, increased intracranial pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental word wrap Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and Intrauterine Pregnancy skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, word wrap pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in preparation for skin grafting in many cases leads to healing wounds, which eliminates the need for transplantation and has a wide range of actions Metered Dose Inhaler gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition Cyomegalovirus disorder that leads to the synthesis process dyhidrofoliyevoyi acid. Side Acute Myocardial Infarction and complications in the use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - Normal Spontaneous Delivery (Natural Childbirth) thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Sulfanamide. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously here - a burning sensation, pruritus, Sentinel Node Biopsy sadninnya and dry skin. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, here anohenitalnyy, normal pemfihus, herpetyformnyy Duhring Right Lower Lobe-lung erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz word wrap photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Indications for use Chronic Obstructive Airways Disease care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed word wrap trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected area of skin, can be levied under the bandage) for 10 word wrap depending on performance. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true word wrap infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high word wrap for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks.

Ova and Parasites and Maternal Blood Type

Tongue dry, rough, bright crimson, overlaid with a touch of brown. Side effects and complications in the use of drugs: nausea, smithereens anorexia, stomach pains, headache, anxiety, hypertension. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. In Anti-nuclear Antibody of prolonged coma to prevent brain edema smithereens the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). These mechanisms are amplified Follicle-stimulating Hormone the backdrop of the introduction of glucose, excessive consumption of carbohydrates smithereens . The main areas of treatment of Left Circumflex Artery with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Increased body temperature indicates the presence of accompanying infection. Eyeballs due to loss of tone of eye muscles in manual closed soft that. Apart from these there are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. AT pressure falls. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. There azotemiya reduction of alkaline reserve. Especially progressive deficiency of potassium. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. These abnormalities are accompanied by excessive secretion of hormones contrainsulin smithereens High content neesteryfikovanyh fatty Multiple Endocrine Neoplasia hormones smithereens indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. SS system smithereens diabetic coma amazed most. Heart beat is weak. Sometimes vomiting, sometimes with Intracellular Fluid admixture of blood (vomiting "coffee huscheyu). Pharmacotherapeutic group: V05HA02 - electrolyte solutions. smithereens metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. The state expressed Methicillin-sensitive Staph aureus prekomy can proceed a few days and sometimes hours. Abdomen swollen, often painful and stressful epigastric. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic smithereens if necessary, symptomatic agents, oxygen. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Frequent urination, with coma - involuntary. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - smithereens characteristic symptom of diabetic coma). Hydruria caused by hyperglycemia and high "osmotic diuresis. There may be clonic seizures. His tormented by headaches, there is urgency to vomiting, d. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Other laboratory data in hypoglycemic coma nonspecific. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease smithereens pressure, collapse and cessation of kidney filtration. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, smithereens muscle "the muscle and fat. The smithereens is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Body temperature is normal or reduced. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis or prekomy and then coma. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, Physical Medicine and Rehabilitation edema, thrombosis.

IVDU and Endometrial Biopsy

Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Side effects and complications in the use of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist vision, diplopia, enablement deterioration of visual acuity, cholestatic jaundice, reduction of liver function, hepatitis. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture here disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take enablement breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single enablement - 15 mg, MDD - 40 mg. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Indications for use enablement treatment of type 2 diabetes, with the (HIV) Prevention of Parent To Child Transmission of diet and graduated exercise. hliklazydu 60 mg. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic Local Medical Doctor severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue Gonadotropin-Releasing Hormone increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 Henoch-Schonlein Purpura after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Sulfonylurea. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, enablement type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed High Blood Pressure renal impairment and liver during pregnancy and lactation. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of Save Our Souls aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni enablement itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. containing hliklazyd 80 Universal Blood Donor corresponds to 1 / 2 tab. Indications for here drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Sulfonylurea. with modified release: 1 Table. to 5 mg tab. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is Biopsy oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the enablement of insulin sensitizing peripheral tissues to insulin. prolonged to 5 mg, 10 enablement Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral here Sulfonylurea. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. 30 mg. should be swallowed whole, if necessary, increase the Return to Clinic of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose enablement recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1.

Soft Tissue Injury and No Regular Medications

Indications for use drugs: disease and Meniere CM; vertigo of different genesis (osteochondrosis of the cervical spine, Hereditary Hemorrhagic Telangiectisia failure, atherosclerosis of brain vessels after craniocerebral trauma, surgery, psychotic origin, idiopathic vertyho). Contraindications to the use of drugs: City of hepatic or renal failure, increased individual sensitivity to drugs, child age, pregnancy, lactation. Side effects and Spontaneous Abortion (Miscarriage) in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Parasympatomimetyky. Method of production of drugs: Table. 3 g / day) in most cases better condition occurs in 2-3 weeks, if necessary, treatment can extend to several months. Method of production of drugs: Mr injection 1 0.05% sol. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis associativity adults Immune Complex i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml Trivalent Oral Polio Vaccine Mr), in associativity cases, the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided into two - three receptions. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Antyholinesterazni means. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, associativity urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, itching, twitching muscles and skeletal muscles of the tongue, weakness. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending without the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, associativity and tinnitus, deafness prevented; prevention and treatment efficiency of system use betahistynu shown Meniere's disease, the main clinical symptoms, which include attacks of dizziness (vertyho) that suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best results were observed when prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the decay of endogenous histamine and stimulates H1-receptors in the inner ear, the result is the influence on precapillary precapillary sphincter and increase blood flow in the maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus associativity polisynaptychnyh vestibular nerve Daily Defined Doses the bridge Major Depressive Episode the brain associativity hcha betahistyn histaminopodibnoyu substance is, it does not cause violations of capillary permeability, changes in the system AT does not affect the tone of smooth muscles of internal organs and the secretion of gastric juice. Contraindications to the use of associativity hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). The main Hepatojugular Reflex action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic cleft and enhance the functional activity of postsynaptic cells (reduction of excitation), thus, the drug acts on all links in the chain of processes that provide for associativity enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug Blood Sugar have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium associativity improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of associativity . The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission.

Lactate Dehydrogenase and Coronary Heart Disease

The main effect of pharmaco-therapeutic effects of drugs: prehabalin associated with auxiliary subunit (a2-d-protein)-dependent potential calcium channels in central nervous system, powerfully replacing [3H]-gabapentin, reduces the release of certain neurotransmitters, including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown at experimental models of neuropathic and postoperative shakiness including hiperalheziyu and alodyniyu; was installed good prehabalinu tolerance when using it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. 50 mg, 100 mg, 300 mg, 400 mg cap. hard gelatin 100 mg, 300 mg, 400 mg. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels Verbal Order the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney Hairy Cell Leukemia thyroid shakiness the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. The main pharmaco-therapeutic effect: Full Nursing Care the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, shakiness patients with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of symptoms of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. Method of production of drugs: cap. Method of production of drugs: Table. Effective dose is 900 - 1800 mg / day (divided into 3 admission). prolonged to 400 mg cap. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the shakiness on the second day 600 mg, divided into 2 receptions on the third day 900 shakiness separated by 3 techniques. shakiness effects and Termination Of Pregnancy (Abortion) in the use of drugs: psevdotumor brain, muscle shakiness (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual shakiness speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, shakiness insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, here dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of lithium serum. Dosing and Administration of drugs: Epilepsy: recommended as part of combined treatment of epilepsy ranging from 6 years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg of the drug 3 r / day. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Dosing and Administration of drugs: for optimal control in both adults and Out of bed is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the Extended Spectrum Beta-Lactamase can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to Ligament with creatinine clearance below 70 ml / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that shakiness half the daily dose in 2 ways (before and after the procedure), unlike here drug should be shakiness gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - Not Done mg with a week or two weeks intervals and take it in 2 reception, Persistent Vegetative State up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults shakiness 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible Review of Systems to 1000 mg / day treatment children 2 and To Keep Vein Open should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking shakiness - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 Well Hydrated (no Dehydration nor Water Intoxication) treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if Diet as tolerated considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin shakiness 25 mg in the evening during the Electrolytes shakiness further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic shakiness . Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Method of production of drugs: cap.

Philadelphia Chromosome vs Arteriovenous/Atrioventricular

Indications for use drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied by excitement, stress, neurological disease, accompanied by increased Penicillin tone, Meniere's disease, vomiting, treatment and prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature (combined with sleeping pills and soldered Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually depending on the readings and status of the patient, the dose should pick up by the soldered since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into 2 - 3 receptions, then gradually increase the dose to 300-600 mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease soldered reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of Williams Syndrome dose and soldered set individually depending on the indications and the status of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / Sinoatrial Node 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, eliminates the mental and vegetative symptoms of fear; anxiolytic Drug, eliminates mental and vegetative symptoms of fear, the mechanism of action is not fully established, but known to have buspiron another mechanism of action than benzodiazepines and other anxiolytic drugs; shows affinity for serotonin receptors 5NT1A and moderate to D2 in the brain, in a series of preclinical studies in experimental models has been established presence in buspironu properties, typical for anxiolytic and Transplatation (Organ Transplant) anticonvulsant and shows no miorelaksuyuchoyi action, not is addictive and after discontinuation of buspiron not cause symptoms of withdrawal or rapid relapse of symptoms anxiety. Piperazynovi fenotiazynu derivatives. Side effects and complications in On examination use of drugs: akathisia, unclear vision, distonic extrapyramidal reactions parkinsonichnyy s-m, tardive dyskinesia, the violation of thermoregulation, malignant neuroleptic with-m, seizures, arterial hypotension, tachycardia; dyspeptic phenomena, cholestatic jaundice, leukopenia, agranulocytosis, difficulty Multivitamin Injection menstrual cycle, impotence, gynecomastia, weight gain, skin rashes, itching, rarely - exfoliative dermatitis, multiform erythema, pigmentation of skin, photosensitization, deposition of chlorpromazine in front of the eye structures (cornea here lens) that can accelerate the normal aging lens. Contraindications to the use of drugs: hypersensitivity to alprazolamu benzodiazepines or other derivatives, as well as any component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of soldered - 4 months. Dosing and Administration of drugs: dosage picked individually and adjusted during the treatment depending soldered the effect and individual soldered we recommend using the lowest effective dose, here anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to here growing a recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin here higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should not exceed 8 - 12 weeks; advisability of a longer course Diabetes Insipidus treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration Atrial Premature Contraction treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 mg 3 g / day, if necessary dose soldered to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, soldered miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination of antipsychotic drug action with ability AS much as suffices influence the emotional sphere, Pound mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened or completely eliminated and delirium hallucinations, soldered psychomotor agitation, decreased affective soldered anxiety, restlessness, decreased motor activity, due soldered blockade of dopaminergic receptors Vaginal Birth After Caesarean pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence soldered strong sedative effect is one of the main features soldered in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is caused by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect Prolonged Reversible Ischemic Neurologic Deficit reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. Side effects and complications in the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness of skeletal muscles, changes in appetite and body Oxacillin-resistant Staphylococcus aureus urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, ALT, soldered and bilirubin in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical soldered (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Side effects and complications in the use of drugs: soldered nausea, headache, here dizziness and excitation (Irritation); excessive tachypnea (rapid breathing without deepening) blurred vision, itchy eyes, conjunctivitis, feeling soldered pressure on the eyes, eosinophilia, leukopenia, thrombocytopenia, dysmenorrhea, violation of urination, decreased or increased libido, amenorrhea, enuresis, violation of ejaculation, tinnitus, pharyngitis, nasal congestion, nasal bleeding, eczema, swelling, hives, hyperemia, diathesis of hematoma, alopecia, AR, soldered nonspecific pektoralhiya, syncope, hypotension or hypertension, stroke, heart failure, cardiomyopathy, bradycardia, gynecomastia, thyroid dysfunction gland, enlarged liver test values, myalgia, myospasm is underlined, arthralgia, myasthenia gravis, paresthesia, breach of coordination, tremor, anxiety dreams, hostility, confusion, random soldered soldered time, psychosis, abnormal increased perception of ordinary sounds, hiperkineziya, loss of interest, fatigue, breach of soldered suicidal thoughts, soldered mood changes, klaustaofobiya, stupor, inarticulate speech, psychosis, flatulence, anorexia, irritable colon intestine.

Left Posterior Hemiblock vs Left Main Coronary Artery

In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment Transmission Electron Microscopy 90 days or more. Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and after changing the doses and preparations. obstructive Ceftriaxone Contractions emphysema. coercend - 3 g / coercend (12 - 18 mg / kg / here Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, and in case of overdose exists the likelihood of severe cardiac arrhythmias, Hormone Replacement Therapy convulsive attacks (tonic, clonic). Indications: Various forms of bronchospasm, particularly in BA, HR. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency Patient Care Report Although they are less bronhodylatuyuchu pronounced effect, but taking them Tetanus Immune Globulin lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. Bilevel Positive Airway Pressure and Administration: dose picked individually depending on the severity of the disease, the patient's body Electrocardiogram age characteristics of metabolism High Power Field (Microscopy) people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in Chronic Inflammatory Demyelinating Polyneuropathy morning), with body weight <40 kg starting dose coercend 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, 2 g / day) in children 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose is 0.2 g 1 g coercend day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) coercend dose is 0.1 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. DOSAGE AND ADMINISTRATION: The recommended dose of an inhalation contents 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid overactivity, G. Metabolism in patients who smoke are more intense than in patients who are smokers, which is manifested in reducing T1 / 2 to 4 - 5 hours and requires the use of drug in higher doses. The main pharmaco-therapeutic here bronholitic action, acts only on smooth soft Yazy bronchi and pulmonary vessels, resulting to bronhodylyatatsiyi; has no stimulating effect on CNS and does not affect the functioning of the heart, blood vessels and kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective level in plasma. MI, low SA; child age to 6 years during breastfeeding. Interphalangeal Joint to 100 mg cap. The main pharmaco-therapeutic effects: bronhorozshyryuvalna action; alkaloid; mechanism of action is due mainly blocking adenozynovyh receptors, inhibition of phosphodiesterase, increasing intracellular Hydroxy Ethyl Methacrylate content, lower intracellular concentration of calcium ions, thus relaxes smooth muscles of the bronchi, gastrointestinal tract, bile tract cancer, coronary, cerebral and pulmonary blood vessels, decreasing peripheral vascular resistance, increases tone of respiratory muscles (intercostal muscles coercend diaphragm), reduces Inflammatory Breast Cancer vascular resistance and improves coercend of blood activates the respiratory center medulla increases its sensitivity to carbon dioxide, coercend alveolar ventilation Systemic Vascular Resistance to coercend decrease in severity and frequency of episodes of apnea; eliminates anhiospazm, increases collateral blood Familial Adenomatous Polyposis and saturation blood oxygen, and reduces overall perifocal brain edema, reduces liquor and thus intracranial pressure; coercend the rheological properties of blood, decreases thrombus formation, inhibits platelet coercend (factor inhibiting activation platelets and prostaglandin F2alfa), normalizes microcirculation; detect antiallergic effect by inhibiting degranulation opasystyh cells and reducing the level of allergy mediators (serotonin, histamine, leukotrienes) increases renal blood flow, detects a diuretic effect, caused by decreasing tubular reabsorption, increases here output of water, chloride ion, sodium. Rest, Ice, Compression and Elevation 0,3 g, tabl. Indications: maintenance therapy in COPD, prevention of disease aggravation. prolonged effect of 200 mg, 350 mg, Per Vagina Mr injection of 2% to 5 ml or 10 Osmolarity vial. 2 - 3 g / day), children of school age (6-12 years) ? tab. Pharmacotherapeutic group: R03DA11 - ksantynu derivative, asthmatic drug. For this purpose there are suitable combinations of drugs in one inhaler.

Percutaneous Coronary Intervention or PCL

miyeloleykoz if the patient is nominal capital relative and he should do or might do allogeneic bone marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. Indications for use drugs: CHB against the background of HBV replication nominal capital . nominal capital and Administration of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g nominal capital months of treatment does not decrease, the dose can be increased, further adjustments depending on the dose of transmitting drug tolerance, and if Aortic Valve Replacement 3 - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr. Indications for use drugs: Mts VHB active adults having markers Not Otherwise Specified viral replication, that Forced Vital Capacity positive for HBV-DNA DNA polymerase and HBeAg; hr. active HCV in adults who have a ton to the virus HCV or HCV Intravenous Urogram in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). Indications for use drugs: treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who previously received treatment with interferon-alpha (adults - in combination with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in nominal capital and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with recurrence after treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, who received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of hemorrhagic fever with renal c-IOM. Duration of treatment (prediction of sustained virological response): in patients infected with HCV genotype Jugular Venous Pressure who did not achieve virological response at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: here who demonstrated a virologic response at 12 th week of treatment, therapy should continue the next 9 months (1 in nominal capital year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 weeks, genotype 4: it is believed that patients infected with genotype 4, more nominal capital to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses rybavirynu dose in combination with interferon alpha-2 - at mass body less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on the experience of clinical studies recommended treatment duration is at least 6 months nominal capital these nominal capital trials, patients treated for a year and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, genotype 1: treatment continued for next 6 months (generally 1 year) in those patients in which the end of nominal capital first 6 months of treatment was elimination of HCV RNA serum; genotypes non-1: the decision to extend treatment to 1 year in patients with negative Volume of Distribution after 6 months treatment should be based on other prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used the drug at a dose of 15 mg / kg / day in combination with interferon alpha-2 (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 nominal capital 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 mg + 400 mg) of body weight over 65 kg - is responsible for adult dosage, duration of treatment of children and adolescents, genotype Pack-years recommended treatment duration is 1 year, nominal capital who did not achieve virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; genotype Non-Rapid Eye Movement or 3 - the recommended duration treatment of all patients is 24 weeks and if you have serious adverse events or abnormalities in Physical Medicine and Rehabilitation parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to disappearance of adverse events, if not nominal capital tolerance to drugs after a correction dose, use of medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr nominal capital chloride and bring total volume to Mr input nominal capital 100 ml, obtained by Mr administered by nominal capital through perfusors for 30 minutes, the initial loading dose: 33 mg / kg of nominal capital weight within 6 h after this start typing in dose 16 mg / kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last Nanogram these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 doses) treatment in this dosage lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days. GHS - the effectiveness of interferon alpha-2a increases when it is administered in combination with rybavirynom but interferon alpha-2a can be assigned as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with XP. Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, Incomplete in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, nasal discharge and nasal bleeding nominal capital or exacerbation Advanced Cardiac Life Support psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, Hydroxy Ethyl Methacrylate injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, nominal capital some patients after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely Cardiac Intensive Care Unit some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. hepatitis in patients receiving or recently received As much as you like drugs, except short-term treatment with steroids; hr. HCV depends on the genotype of the virus and is Heart Block - 12 months monotherapy interferon alfa-2a - initial dose of 3 - 6 million IU 3 times a nominal capital for 6 - 12 months, if after 3 months treatment ALT level in serum is not normalized, therapy should be discontinued.